Arena BioWorks
@arenabioworks
Arena BioWorks is focused on uncovering the mechanisms of human disease to identify opportunities for therapeutic intervention.
We are delighted to see our own @SchreiberStuart recognized for his pioneering work in chemical biology, which has yielded decades of impact and much more to come! Congrats Stuart and Dr. Peter G. Schultz on receiving the @WelchFoundation #WelchAward
The Welch Foundation is pleased to announce the 2025 Welch Award in Chemistry recipients: Dr. Stuart L. Schreiber of @Harvard and Arena BioWorks, and Dr. Peter G. Schultz of @scrippsresearch. Both are being recognized for their groundbreaking contributions to the field of…
Under this ownership group, the Celtics won two championships and built a culture of camaraderie and resilience. Steve's deep loyalty to Boston makes him a champion both on and off the court, leaving a legacy that will forever inspire Celtics fans and Bostonians alike.
Here's my statement on today's news.
We love to spotlight those team members with roles whose visibility runs counter to their success. The smoother the lab runs, the easier it is to forget that people like Suzannah, with her no-nonsense, can-do demeanor, are the backbone of everything we are doing here.
Congrats to the winners of the Stuart L. Schreiber Prize in Scientific Excellence presented at the @broadinstitute 's annual retreat! @JiaqiZhangVic (top) won for outstanding work on causal inference AI and @Smriti__Pandey (bottom) for pushing the frontiers of genome editing.

Arena co-founder @SchreiberStuart, together with Doug Melton and Michael Mina, talked to @HarvardMagazine about recognizing an opportunity to transform medicine by overcoming inherent inefficiencies in the current ecosystem. harvardmagazine.com/2025/01/harvar…
It's been a year of growth for Arena, so we were delighted to strengthen bonds and forge new ones while flexing our arcade skills at the holiday party. As we look ahead to the next year, Arena's focus continues to be human-biology-first. Emphasis on human.

We are delighted to congratulate Arena co-founder @SchreiberStuart (2nd from right) on being awarded the Robert Koch Gold Medal in Berlin last week by the Robert Koch Foundation, a non-profit dedicated to supporting science. Photo ©RobertKochStiftung

Dave is a dreamer and a doodler who won our first t-shirt design contest, but you won't find him at the back of the class. His laid-back vibe belies a mind bursting with ideas and insights that challenge, inspire, and fuel an infectious desire to turn them into hope for patients.
Ziyi Chen and Alex Wolff popped over from Arena to talk about challenges in predicting protein binding to small molecules at Connecting the Dots: Biology at Scale in the Age of AI, hosted by @broadinstitute.

Dara Leto exudes the gentle selflessness of a true dog person. But when it comes to finding opportunities to reach across disciplines and form meaningful collaborations, she is as tenacious as the objects of her affection and has just as good a nose for finding worthwhile paths.
First-time dad Travis Blum knows that bringing something new into the world is hard, messy work, and about the most rewarding thing a person can do. He reaches beyond his job description to help in any way he can, his apologetic smile forever signaling regret for time's finitude.
Nicole, like many, charted her course during the Great Recession. Opting to forgo a Ph.D. (you'd never guess), she forged on to become a leader in computational biology—most recently at Pfizer—while building a family. She is thrilled to see today's buffet of post-Ph.D. options.
Congrats to the team at Jnana Tx! Founding team includes our own founding CEO @schreiberstuart. Jnana's story is a powerful example of the importance of understanding the mechanisms of human disease and finding the right clinical biomarkers. Big step closer to reaching patients.
Jnana announced today that it has entered into an agreement to be acquired by Otsuka Pharmaceutical. bit.ly/4ftndW9 #biotech #news
Hallmark of oncogenic mutant p53? Exceptionally high levels of expression. How to exploit for treating cancers? A bifunctional Chemical Inducer of Proximity (CIP) that targets a cytotoxic small molecule to mutant p53 cancers. See thread by @wgibson
TP53: - Discovered 45 years ago, most cited gene all time - No therapies - 500 million people currently living will die of TP53 mutant cancers without new therapies Our Preprint: - A general strategy for TP53 missense mutant cancers (majority) with prototype small molecules
Always good for a laugh, Dan Gray—voted most likely to reference the Peloponnesian War while talking science—hails from a literary family. Though he broke from tradition to study science, he reads voraciously, and his interests—like his thinking—run both broad and deep.
Arena's first Summer Social was a smashing success! It was a warm welcome for many new faces and a bittersweet sendoff for three research associates who helped turn the Arena dream into a reality and are now taking their hard work and grit to graduate school.

Ken Lam is as humble as they come, but don't be mistaken. During presentations, his kindly asked but searingly insightful questions have been known to leave jaws on the floor. Penetrating minds like his are invaluable to shortening the path from insights to therapeutics.
Like some modern-day reverse Christopher Wren, Tasos might have been an architect but brought his design sense to the molecular scale. Fueled by espresso, this physician-scientist-dad-of-a-toddler never loses sight of the potential impact of his role. He could use a nap though.
Polyglot Giulia Oliva speaks English, Greek, French, and her native Italian. She would love to learn more but is busy with another manner of translation—turning her splendido mind to generating insights in the lab that she hopes to translate to new ways of treating disease.
When Martha walked into Arena's first holiday party and saw chalk drawings of holly in the shape of DNA, she didn't see a decoration. She saw an invitation. We celebrate our doodlers, designers, musicians, and artists of all kinds. Creativity out of lab begets creativity in lab.